维普期刊资源整合服务平台（V6.5）

2285篇 您的检索式：期刊名="Clin Pharmacokinet"

选中清除导出查看参考文献查看引证文献引用追踪共115页首页上一页第1页下一页末页 /115 跳转

	题名	作者	年代	出处	被引量
1	A retrospective analysis of pharmacokinetic-pharmacodynamic parameters as indicators of the clinical efficacy of ceftizoxime 显示文摘	Sanchez-Navarro A Colino C I Sanchez Recio M M	2001	Clin Pharmacokinet2001，40，2：	2
2	Effects of obesity on pharmacokinetics implications for drug therapy显示文摘	Cheymol G	2000	Clin Pharmacokinet2000，39，3：	1
3	General framework for the quantitative of CYP3A4-mediated oral drug interactions based on the AUC increase by coadministration of standerd drugs显示文摘	Ohno Y Hisaka A Suzuki H	2007	Clin Pharmacokinet2007，46，8：	1
4	Clinical pharmacokinetics of candesartan显示文摘	Gleiter CH Morike KF	2002	Clin Pharmacokinet2002，41，1：	1
5	Clinical pharmacokinetics of mycophenolate mofetil显示文摘	Bullingham RE Nicholls AJ Kamm BR	1998	Clin Pharmacokinet1998，34，6：	1
6	Clinical pharmacokinetic profile of modafinil显示文摘	Philmore RJ Edward TH	2003	Clin Pharmacokinet2003，42，2：	1
7	Pharmacokinetic- pharmaeodynamic relationship of the selective serotonie reuptake inhibitors显示文摘	Baumann P	1996	Clin Pharmacokinet1996，31，：	1
8	Buprenorphine:clinical pharmacokinetics in the treatment of opioid dependence显示文摘	Elkader A Sproule B	2005	Clin Pharmacokinet2005，44，7：	1
9	Pharmacokinetics and tolerability of the orally active selective epidermal growth factor receptor tyrosine kinase inhibitor ZD1839in healthy volunteers显示文摘	Swaisland H Laight A Stafford L	2001	Clin Pharmacokinet2001，40，2：	1
10	Clinical pharmacokinefics of tacrolimus 显示文摘	VENKATARAMANAN R SWAMINATHAN A PRASAD T	1995	Clin Pharmacokinet1995，29，：	1
11	Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease显示文摘	Deleu D Northway MG Hanssens Y	2002	Clin Pharmacokinet2002，41，4：	1
12	Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesianmodelling in kidney transplant recipients 显示文摘	Djebli N Rousseau A Hoizey G	2006	Clin Pharmacokinet2006，45，11：	1
13	Clinical pharmacokinetics of losartan 显示文摘	DOMENIC A S TODD W B G SIDDHARTHAT G	2005	Clin Pharmacokinet2005，44，8：	1
14	Role of p glycoprotein inhibition for drug interactions: evi- dence from in vitro and pharmacoepidemiological studies显示文摘	Eberl S Renner B Neubert A	2007	Clin Pharmacokinet2007，46，12：	1
15	Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I 显示文摘	Zhou SF	2009	Clin Pharmacokinet2009，48，11：	1
16	Clinical pharmacokinetics and pharmacodymanics of tacrolimus in solid oorgan transplantation显示文摘	Staatz CE Tett SE	2004	Clin Pharmacokinet2004，43，10：	1
17	Population phar- macokinetic analysis during the first 2 years of life 显示文摘	Marsot A Boulamery A Bruguerolle B	2012	Clin Pharmacokinet2012，51，12：	1
18	A mechanism-based population pharmacokinetic model for characterizing time-dependent pharmacokinetics of midostaurin and its metabolites in human subjects显示文摘	Yin OQ Wang Y Schran H		Clin Pharmacokinet0，47，12：	1
19	Lack of clinically relevant interaction between desloratadine and erythromycin显示文摘	Banfield C Hunt T Reyderman L	2002	Clin Pharmacokinet2002，41，1：	1
20	Drug interactions with tobacco smoking显示文摘	Zevin S Benowitz NL	1999	Anupdate Clin Pharmacokinet1999，36，2：	1

返回顶部每页显示：

共115页首页上一页第1页下一页末页 /115 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示